Discover our ready to use inks

Find products by 3D print technology

Inks for Deposition-based 3D Printing
Inks for Deposition-based 3D Printing
/products?f%5B0%5D=print-tech%3A1
Inks for Multiphoton Lithography
Inks for Multiphoton Lithography
/products?f%5B0%5D=print-tech%3A2
DLP/SLA
Inks for Digital Light Processing & Stereolithography
/products?f%5B0%5D=print-tech%3A3
Volumetric printing
Inks for Volumetric Printing
/products?f%5B0%5D=print-tech%3A36

Discover our bio ink precursors

Precursors
See all precursors
  • Our Mission

    Our Mission

    By developing and offering high quality bioinks and biomaterials, we aim to be your support in bioprinting to bring tissue engineering and regenerative medicine closer to clinical reality! To do so we provide researchers, clinicians and industry the unique tools for break-through research.

  • Our Expertise

    Our Expertise

    At BIO INX®, we are focusing on the commercialisation of materials and bioinks for 3D bioprinting by utilizing decades of academic experience in the field of polymers and biomaterials.

    Learn more
  • Our Team

    Our Team

    Our multidisciplinary team with backgrounds in chemistry and biomedical engineering has a combined 20 years of expertise in the field of polymers, (bio)materials, 3D printing and tissue engineering. Therefore we can provide you with the best possible solutions for all your biofabrication needs.

    Learn more

Latest news

  • Advancing Cancer Research with 3D Bioprinting

    Advancing Cancer Research with 3D Bioprinting: New Study Highlights the Potential of HYDROBIO INX U200

    February 3, 2025

    A groundbreaking study published in APL Bioengineering demonstrates how advanced 3D bioprinting can revolutionize cancer research by providing realistic in vitro models to study tumor invasion. The research, led by Federico Cantoni and colleagues, of the Maria Tenje Lab at Uppsala University showcases the use of multiphoton lithography to fabricate hydrogel scaffolds that mimic the ECM.

  • BIORES INX

    BIO INX Announces the Launch of BIORES INX: A Groundbreaking Gelatin-Based DLP Resin for Bioprinting

    December 2, 2024

    BIO INX Launches BIORES INX: A Gelatin-Based DLP Resin for Bioprinting
    BIO INX introduces BIORES INX, a groundbreaking gelatin methacrylamide (GelMA)-based resin for digital light processing (DLP) bioprinting. This resin combines exceptional biocompatibility, ease of use, and cross-platform compatibility, eliminating challenges like heating and water evaporation during printing.

  • Bio INX & Carl Roth

    BIO INX and Carl ROTH Partner to Expand Access to 3D Bioprinting Solutions

    November 26, 2024

    BIO INX and Carl ROTH partner to make advanced bioinks more accessible worldwide. Carl Roth now offers BIO INX’s full portfolio, supporting innovations in tissue engineering and regenerative medicine. This collaboration streamlines logistics and accelerates bioprinting advancements. Explore the range at www.carlroth.com

More news

Upcoming events

  • Join BIO INX at TERMIS EU 2025 in Freiburg!

    Join BIO INX at TERMIS EU 2025 in Freiburg!

    Takes place on
    Tuesday, May 20, 2025

    BIO INX Supports TERMIS EU 2025 in Freiburg!

    BIO INX is delighted to participate in the TERMIS EU 2025 Congress, a pivotal event in tissue engineering and regenerative medicine.

  • ESB

    34th Annual Conference of the European Society for Biomaterials

    Takes place on
    Sunday, September 7, 2025

    The 34th Annual Conference of the European Society for Biomaterials will take place from September 7 to 11, 2025 in Turin, Italy.
    The motto of the ESB 2025 conference is “Biomaterials on the horizon”. The horizon opens our mind to new and at times unexpected discoveries, and reminds us of the charming challenges of our research.

  • Microtas

    Microtas 2025

    Takes place on
    Sunday, November 2, 2025

    The 29th International Conference on Miniaturized Systems for Chemistry and Life Sciences -
    Micro-Total Analysis Systems (µTAS 2025)

    Conference Chairs:
    Michael Breadmore, University of Tasmania, AUSTRALIA
    Rosanne Guijt, Deakin University, AUSTRALIA
    Craig Priest, University of South Australia, AUSTRALIA